Delivery Order SPE2DB24D9105-SPE2DB25FBYUC

Award Date 4/28/25
Potential Completion Date 5/19/25
Potential Value $9.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,536.45 firm fixed-price delivery order is for the supply of 4567403459 ! LIVDELZI 10 MG CAPSULE 30S, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
This federal contract award, with a value of $19,072.90, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4567099452 ! LIVDELZI 10 MG CAPSULE 30S, a specialized pharmaceutical product. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $19,072.90, is for the delivery of 4567908783 LIVDELZI 10 MG CAPSULE 30S. The contract has an ultimate completion date of May 1, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge, Illinois, and has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,536.45 firm fixed-price delivery order is for the supply of LIVDELZI 10 MG CAPSULE 30S, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,536.45 firm fixed-price delivery order is for the provision of LIVDELZI 10 MG CAPSULE 30S, a specialized pharmaceutical product, with a period of performance through January 22, 2025. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) valued at $499,999,999 with...
The federal contract award summarized in the provided information was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $47,682.25 firm fixed-price delivery order contract is for the supply of 4567099427 LIVDELZI 10 MG CAPSULE 30S, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $19,072.90 firm fixed-price delivery order contract is for the supply of 4567925920 LIVDELZI 10 MG CAPSULE 30S, a specialized pharmaceutical product. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $19,072.90, is a delivery order under the SPE2DB indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA. The IDC is valued at $499,999,999 and is valid through November 2026. The contract is for the delivery of LIVDELZI 10 MG CAPSULE 30S, a pharmaceutical product, with a performance...
This federal contract award, with the ID SPE2DX15D9114|SPE2DX25F5ZKG, was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $28,609.35 firm fixed-price delivery order is for the supply of LIVDELZI 10 MG CAPSULE 30S, a pharmaceutical product, with a completion date of December 10, 2024. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract, valued at $28,609.35, is for the delivery of 4567099428 ! LIVDELZI 10 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through February 19, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
  • SPE2DB24D9105
    Indefinite Delivery Contract
  • SPE2DB24D9105-SPE2DB25FBYUC
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a Delivery Order (DO) under the SPE2DB Indefinite Delivery Contract (IDC) valued at up to $9,536.45. The DO is for the supply of 4568087353 ! LIVDELZI 10 MG CAPSULE 30S, with a period of performance ending on May 19, 2025. This contract does not have a set-aside designation. The DLA is the funding agency, and DMS Pharmaceutical Group Inc. is the prime contractor. As a woman-owned small business, DMS Pharmaceutical Group Inc. has a significant IDC with the DLA under the SPE2DB program, valued at up to $499,999,999 and valid through November 2026, to provide a comprehensive range of pharmaceutical products to military health facilities worldwide.

Generated 7/28/25, 11:10 AM